Učitavanje...
A bone marrow toxicity model for (223)Ra alpha-emitter radiopharmaceutical therapy
PURPOSE: Ra-223, an α-particle emitting bone-seeking radionuclide, has recently been used in clinical trials for osseous metasteses of prostate cancer. We investigated the relationship between absorbed fraction-based red marrow dosimetry and cell level-dosimetry using a model that accounts for the e...
Spremljeno u:
| Glavni autori: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2012
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3442928/ https://ncbi.nlm.nih.gov/pubmed/22546715 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1088/0031-9155/57/10/3207 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|